Axsome Therapeutics AXSM
NASDAQ AXSM
$182.07 -2.32 (-1.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Accounts Payables (2015 - 2026)

Updated

Axsome Therapeutics (AXSM) posted Accounts Payables of $299.63 million for Q2 2026, up 75.3% from $170.9 million a year earlier and up 19.5% from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Accounts Payables (2015 - 2026) Analysis & Trends

At the end of FY2025, Axsome Therapeutics' Accounts Payables came in at $232.85 million, up 57.3% from FY2024.

  • Annual Accounts Payables has increased for four consecutive years, with a five-year compound annual growth rate of 76.7% (FY2020 to FY2025).
  • In prior years, Axsome Therapeutics' Accounts Payables was $147.99 million in FY2024 (+63.5%), $90.5 million in FY2023 (+75.3%), $51.63 million in FY2022 (+292.7%) and $13.15 million in FY2021 (-2.6%).
  • The Q2 2026 figure stands as the highest quarterly Accounts Payables in data going back to Q4 2015.
  • On a year-over-year basis, Accounts Payables has increased in each of the last 17 quarters, with growth averaging 66.4% over the last eight quarters.
  • The strongest year-over-year quarter for Accounts Payables in the past five years was Q1 2023, with growth of 366.6%; the weakest was Q1 2022, with a decline of 13.9%.
  • According to Business Quant data, Accounts Payables for the three prior quarters was $250.73 million (Q1 2026), $232.85 million (Q4 2025) and $225.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Axsome Therapeutics 9.64 Bn 8.37 Bn 204.81 Mn 299.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 299.63 Mn
Mar 31, 2026 250.73 Mn
Dec 31, 2025 232.85 Mn
Sep 30, 2025 225.63 Mn
Jun 30, 2025 170.90 Mn
Mar 31, 2025 149.20 Mn
Dec 31, 2024 147.99 Mn
Sep 30, 2024 122.18 Mn
Jun 30, 2024 116.77 Mn
Mar 31, 2024 82.72 Mn
Dec 31, 2023 90.50 Mn
Sep 30, 2023 78.45 Mn
Jun 30, 2023 65.32 Mn
Mar 31, 2023 58.77 Mn
Dec 31, 2022 51.63 Mn
Sep 30, 2022 40.02 Mn
Jun 30, 2022 19.43 Mn
Mar 31, 2022 12.60 Mn
Dec 31, 2021 13.15 Mn
Sep 30, 2021 13.38 Mn
API Access

Axsome Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=AXSM&period=max&api_key=YOUR_API_KEY